tirzepatide osa study (Zepbound) – A New Treatment for Obstructive Sleep Apnea and Obesity — BetterNight Tirzepatide - A New Dawn

Murugan R, Tamil Selvan S, Dharmalingam Jothinathan MK, Srinivasan GP, Rajan Renuka R, Prasad M

Results: Progressive and individualized

Animal studies yielded promising results, including increased grip strength and enhanced skeletal muscle cross-sectional area (CSA), while body weight remained stable within a defined dosage range

Retatrutide may deliver greater weight loss than existing drugs by acting on three hormones, but risks like side effects, muscle loss, and emotional changes remain concerns.

Researchers continue to study its molecular characteristics, peptide structure and biochemical behaviour using validated laboratory techniques and analytical methods

Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data